Generation and characterization of a mutant of influenza A virus selected with the neuraminidase inhibitor RWJ-270201

被引：0

作者：

Bantia, S

Ananth, S

Horn, L

Parker, C

Gulati, U

Chand, P

Babu, Y

Air, G

机构：

[1] BioCyst Pharmaceut Inc, Birmingham, AL USA

[2] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK 73190 USA

来源：

ANTIVIRAL RESEARCH | 2000年 / 46卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：A60 / A60

页数：1

共 50 条

[1] In vivo influenza virus-inhibitory effects of the cyclopentane neuraminidase inhibitor RWJ-270201
Sidwell, RW
Smee, DF
Huffman, JH
Barnard, DL
Bailey, KW
Morrey, JD
Babu, YS
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (03) : 749 - 757
[2] RWJ-270201 (BCX-1812): a novel neuraminidase inhibitor for influenza
Young, D
Fowler, C
Bush, K
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2001, 356 (1416) : 1905 - 1913
[3] Characterization of an influenza A (H3N2) virus resistant to the cyclopentane neuraminidase inhibitor RWJ-270201
Smee, DF
Sidwell, RW
Morrison, AC
Bailey, KW
Baum, EZ
Ly, L
Wagaman, PC
ANTIVIRAL RESEARCH, 2001, 52 (03) : 251 - 259
[4] RWJ-270201 - BCX-1812 - Anti-influenza - Neuraminidase inhibitor
不详
DRUGS OF THE FUTURE, 2001, 26 (03) : 312 - 315
[5] Combination treatment of influenza A virus infections in cell culture and in mice with the cyclopentane neuraminidase inhibitor RWJ-270201 and ribavirin
Smee, DF
Bailey, KW
Morrison, AC
Sidwell, RW
CHEMOTHERAPY, 2002, 48 (02) : 88 - 93
[6] Primary immune system effects of the orally administered cyclopentane neuraminidase inhibitor RWJ-270201 in influenza virus-infected mice
Sidwell, RW
Smee, DF
Bailey, KW
Burger, RA
INTERNATIONAL IMMUNOPHARMACOLOGY, 2001, 1 (06) : 1211 - 1218
[7] Synthetic challenges of the neuraminidase inhibitor RWJ-270201: From grams to tons.
Sorgi, KL
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 222 : U69 - U69
[8] Comparison of the activities of zanamivir, oseltamivir, and RWJ-270201 against clinical isolates of influenza virus and neuraminidase inhibitor-resistant variants
Gubareva, LV
Webster, RG
Hayden, FG
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (12) : 3403 - 3408
[9] A pharmacodynamic evaluation of a murine model of influenza predicts efficacy for once daily dosing of RWJ-270201, a novel neuraminidase inhibitor.
Drusano, GL
Preston, SL
Smee, D
Bush, K
Bailey, K
Sidwell, R
ANTIVIRAL RESEARCH, 2000, 46 (01) : A58 - A58
[10] Generation and characterization of a mutant of influenza A virus selected with the neuraminidase inhibitor BCX-140
Bantia, S
Ghate, AA
Ananth, SL
Babu, YS
Air, GM
Walsh, GM
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (04) : 801 - 807

← 1 2 3 4 5 →